98 results
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
14 May 24
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
4:05pm
annually,” said Eric Schlorff, SeaStar Medical CEO. “Our launch strategy entails qualifying five prominent children’s hospitals as the first to offer … for a clinical trial to evaluate the SCD-ADULT as a bridging strategy to left ventricular assist device implantation in patients with chronic heart failure
8-K
EX-99.1
d7ft 73yel
17 Apr 24
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
4:01pm
8-K/A
EX-99.1
iscgnyfzaj7kmjkwu236
27 Mar 24
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
5:23pm
8-K
6lr3eht03exn w6rh
27 Mar 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8:35am
8-K
EX-99.1
90ljhqu
27 Mar 24
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
8:32am
424B3
ov722tx5p
5 Mar 24
Prospectus supplement
5:08pm
424B3
ihsq54cq5i6ay15damof
5 Mar 24
Prospectus supplement
5:06pm
424B3
fge7f2
5 Mar 24
Prospectus supplement
5:04pm
424B3
n9i6pl
5 Mar 24
Prospectus supplement
4:59pm
424B3
t207s 5i4kq1q8m
5 Mar 24
Prospectus supplement
4:56pm
8-K
EX-99.1
2aioykaubm4z3312
22 Feb 24
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
8:00am
8-K
EX-99.1
ngpzw9qmpkup
30 Jan 24
SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market
9:18am
8-K
EX-99.1
46w3b6n 0vcu20
11 Jan 24
SeaStar Medical Appoints David A. Green as Chief Financial Officer
4:10pm
8-K
EX-99.1
5yn0ajtz
21 Nov 23
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
6:04pm
8-K
EX-99.1
gdstyiu
30 Oct 23
FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients
8:15am